Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | 12-2005 | |
| Sales | 55,238 | 0 | 0 | 0 |
| Gross Profit | 55,238 | N/A | N/A | N/A |
| Operating Expenses | 34,681 | 0 | 0 | 0 |
| Operating Income | 20,557 | N/A | N/A | N/A |
| Interest Expense | 469 | 0 | 0 | 0 |
| Other Income | 30 | 0 | 0 | 0 |
| Pre-tax Income | 20,118 | 0 | 0 | 0 |
| Net Income Continuous | 20,118 | N/A | N/A | N/A |
| Net Income | $20,118 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | 7.90 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | 7.92 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 7.40 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | 7.45 | N/A | N/A | N/A |
| EBITDA(a) | $21,105 | $N/A | $N/A | $N/A |